Results 301 to 310 of about 137,029 (384)

Infliximab-associated bilateral nonarteritic ischemic optic neuropathy in chronic plaque psoriasis treatment. [PDF]

JAAD Case Rep
Currier J, Abraham T, Murakawa GJ.
europepmc   +1 more source

THU0181 Clinical results of an open labelled evaluation of the treatment with infliximab in therapy resistant rheumatoid arthritis

, 2001
Marita Spak, E Cauza, Ursula Hanusch, G Haberhauer, Attila Dunky   +4 more
openalex   +1 more source

Post Hoc Analysis of Anxiety and Behavioral Changes in Japanese Patients With Inflammatory Bowel Disease due to the COVID‐19 Pandemic: Relationship Between Municipal Population at the Place of Residence and Anxiety

JGH Open, Volume 9, Issue 7, July 2025.
ABSTRACT Aims The Japan COVID‐19 Survey and the Questionnaire for Inflammatory Bowel Disease (J‐DESIRE) identified multiple factors associated with anxiety regarding the novel coronavirus disease 2019 (COVID‐19). However, no regional differences in anxiety were observed.
Kohei Wagatsuma, Masanori Nojima, Takayuki Matsumoto, Minoru Matsuura, Hideki Iijima, Katsuyoshi Matsuoka, Naoki Ohmiya, Shunji Ishihara, Fumihito Hirai, Ken Takeuchi, Satoshi Tamura, Fukunori Kinjo, Nobuhiro Ueno, Makoto Naganuma, Kenji Watanabe, Rintaro Moroi, Nobuaki Nishimata, Satoshi Motoya, Koichi Kurahara, Sakuma Takahashi, Atsuo Maemoto, Hiroto Hiraga, Masayuki Saruta, Keiichi Tominaga, Takashi Hisabe, Hiroki Tanaka, Shuji Terai, Toshihiro Inokuchi, Hironobu Takedomi, Kazuyuki Narimatsu, Katsuya Endo, Masanao Nakamura, Tadakazu Hisamatsu, Hiroshi Nakase, on behalf of J‐DESIRE Group, Sae Ohwada, Takehiro Hirano, Yoshihiro Yokoyama, Tsukasa Yamakawa, Yuki Hayashi, Tadashi Ichimiya, Tomoe Kazama, Daisuke Hirayama, Ayuko Hazumi, Ayumi Kadoya, Saki Asakura, Naomi Ebisawa, Shunichi Yanai, Daisuke Saito, Shinichiro Shinzaki, Akihiro Yamada, Mitsuo Nagasaka, Kousaku Kawashima, Nobuaki Kuno, Yoshihiro Shimoyama, Ken Sugimoto, Nobufumi Uchima, Mikihiro Fujiya, Norimasa Fukata, Yoko Yokoyama, Atsushi Masamune, Yukinori Sameshima, Ryosuke Kiyomori, Tomoki Inaba, Takahiro Ito, Hirotake Sakuraba, Takahiko Toyonaga, Takanao Tanaka, Akihiro Koga, Masanao Nasuno, Yuzo Kawata, Sakiko Hiraoka, Motohiro Esaki, Ryota Hokari, Yuki Yoshino   +74 more
wiley   +1 more source

Managing IEC-associated enterocolitis following CAR-T therapy in multiple myeloma. [PDF]

Blood Cancer J
Banerjee R, Hosoya H, Mikkilineni L, Hansen DK, Wolf JL, Lin Y.   +5 more
europepmc   +1 more source

OP0056 Tnf-alpha blockade with infliximab in patients with active spondyloarthropathy: follow-up of one year maintenance regimen

, 2001
Elli Kruithof, Filip Van den Bosch, Dominique Baeten, Filip De Keyser, Herman Mielants, E M Veys   +5 more
openalex   +1 more source

A Randomized Double‐Blind, Placebo‐Controlled Trial of Artesunate and Curcumin in Patients With Crohn's Disease: A Pilot Study

JGH Open, Volume 9, Issue 7, July 2025.
ABSTRACT Aim Less than half of all patients with Crohn's disease remain in remission with long‐term use of azathioprine. Our aim was to assess the efficacy of Artesunate and Curcumin in maintaining remission in patients with Crohn's disease, who had ongoing evidence of disease activity despite taking azathioprine.
Devinder Kumar, Uday C Ghoshal, Vamika Mansi Saigal, Moni Chaudhary, Shikha Sahu, Vishruti Pandya, Ujjala Ghoshal   +6 more
wiley   +1 more source

Osseous Sarcoidosis: Three Typical Presentations of an Atypical Disease. [PDF]

Cureus
Ray LC, Ayele F.
europepmc   +1 more source

OP0066 Effects of tnf blockade with infliximab in patients with primary sjÖgren’s syndrome: an open pilot study

, 2001
S Steinfeld, Paul Demols, Valérie Gangji, Thierry Appelboom   +3 more
openalex   +1 more source

Anti‐Inflammatory Peptides as Promising Therapeutics Agent Against Inflammatory Bowel Diseases: A Systematic Review

JGH Open, Volume 9, Issue 7, July 2025.
ABSTRACT Background Inflammatory bowel disease (IBD) is linked to dysregulated mucosal immunity, microbiota imbalances, and environmental factors, though its exact cause remains unknown. Current treatments often have limitations, necessitating innovative therapies.
Kiarash Ghazvini, Zahra Taghiabadi, Mohammad Ali Karimi, Mahdi Hosseini Bafghi, Mahdiesadat Paryan, Razieh Amirfakhrian   +5 more
wiley   +1 more source